Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EBITDA: 2009-2025

Historic EBITDA for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to $34.6 million.

  • Innoviva's EBITDA fell 20.03% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year decrease of 20.36%. This contributed to the annual value of $7.8 million for FY2024, which is 80.74% down from last year.
  • Per Innoviva's latest filing, its EBITDA stood at $34.6 million for Q3 2025, which was down 29.07% from $48.8 million recorded in Q2 2025.
  • In the past 5 years, Innoviva's EBITDA registered a high of $96.5 million during Q2 2021, and its lowest value of -$11.3 million during Q1 2023.
  • Over the past 3 years, Innoviva's median EBITDA value was -$6.6 million (recorded in 2023), while the average stood at $18.2 million.
  • In the last 5 years, Innoviva's EBITDA slumped by 109.55% in 2022 and then skyrocketed by 1,515,300.00% in 2023.
  • Over the past 5 years, Innoviva's EBITDA (Quarterly) stood at -$6.0 million in 2021, then plummeted by 70.77% to -$10.3 million in 2022, then surged by 36.31% to -$6.6 million in 2023, then crashed by 60.22% to -$10.5 million in 2024, then fell by 20.03% to $34.6 million in 2025.
  • Its EBITDA was $34.6 million in Q3 2025, compared to $48.8 million in Q2 2025 and -$8.2 million in Q1 2025.